389 related articles for article (PubMed ID: 21310958)
1. MicroRNA-29c is a signature microRNA under high glucose conditions that targets Sprouty homolog 1, and its in vivo knockdown prevents progression of diabetic nephropathy.
Long J; Wang Y; Wang W; Chang BH; Danesh FR
J Biol Chem; 2011 Apr; 286(13):11837-48. PubMed ID: 21310958
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of miR-34c inhibits high glucose-induced apoptosis in podocytes by targeting Notch signaling pathways.
Liu XD; Zhang LY; Zhu TC; Zhang RF; Wang SL; Bao Y
Int J Clin Exp Pathol; 2015; 8(5):4525-34. PubMed ID: 26191142
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-218 promotes high glucose-induced apoptosis in podocytes by targeting heme oxygenase-1.
Yang H; Wang Q; Li S
Biochem Biophys Res Commun; 2016 Mar; 471(4):582-8. PubMed ID: 26876575
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-26a inhibits TGF-β-induced extracellular matrix protein expression in podocytes by targeting CTGF and is downregulated in diabetic nephropathy.
Koga K; Yokoi H; Mori K; Kasahara M; Kuwabara T; Imamaki H; Ishii A; Mori KP; Kato Y; Ohno S; Toda N; Saleem MA; Sugawara A; Nakao K; Yanagita M; Mukoyama M
Diabetologia; 2015 Sep; 58(9):2169-80. PubMed ID: 26063197
[TBL] [Abstract][Full Text] [Related]
5. RhoA protects the podocytes against high glucose-induced apoptosis through YAP and plays critical role in diabetic nephropathy.
Huang Z; Peng Y; Yu H; Yu X; Zhou J; Xiao J
Biochem Biophys Res Commun; 2018 Oct; 504(4):949-956. PubMed ID: 30220545
[TBL] [Abstract][Full Text] [Related]
6. Identification of microRNA-93 as a novel regulator of vascular endothelial growth factor in hyperglycemic conditions.
Long J; Wang Y; Wang W; Chang BH; Danesh FR
J Biol Chem; 2010 Jul; 285(30):23457-65. PubMed ID: 20501654
[TBL] [Abstract][Full Text] [Related]
7. Absence of miR-146a in Podocytes Increases Risk of Diabetic Glomerulopathy via Up-regulation of ErbB4 and Notch-1.
Lee HW; Khan SQ; Khaliqdina S; Altintas MM; Grahammer F; Zhao JL; Koh KH; Tardi NJ; Faridi MH; Geraghty T; Cimbaluk DJ; Susztak K; Moita LF; Baltimore D; Tharaux PL; Huber TB; Kretzler M; Bitzer M; Reiser J; Gupta V
J Biol Chem; 2017 Jan; 292(2):732-747. PubMed ID: 27913625
[TBL] [Abstract][Full Text] [Related]
8. Metadherin facilitates podocyte apoptosis in diabetic nephropathy.
Liu WT; Peng FF; Li HY; Chen XW; Gong WQ; Chen WJ; Chen YH; Li PL; Li ST; Xu ZZ; Long HB
Cell Death Dis; 2016 Nov; 7(11):e2477. PubMed ID: 27882943
[TBL] [Abstract][Full Text] [Related]
9. MiR-33a Overexpression Exacerbates Diabetic Nephropathy Through Sirt6-dependent Notch Signaling.
Wang Y; Dai S; Yang J; Ma J; Wang P; Zhao X; Liu J; Xiao A; Song Y; Gao L
Iran J Kidney Dis; 2024 May; 18(3):168-178. PubMed ID: 38904337
[TBL] [Abstract][Full Text] [Related]
10. Variations in MicroRNA-25 Expression Influence the Severity of Diabetic Kidney Disease.
Liu Y; Li H; Liu J; Han P; Li X; Bai H; Zhang C; Sun X; Teng Y; Zhang Y; Yuan X; Chu Y; Zhao B
J Am Soc Nephrol; 2017 Dec; 28(12):3627-3638. PubMed ID: 28923913
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of p53/miR-34a/SIRT1 axis ameliorates podocyte injury in diabetic nephropathy.
Liang Y; Liu H; Zhu J; Song N; Lu Z; Fang Y; Teng J; Dai Y; Ding X
Biochem Biophys Res Commun; 2021 Jun; 559():48-55. PubMed ID: 33932899
[TBL] [Abstract][Full Text] [Related]
12. Circ-AKT3 inhibits the accumulation of extracellular matrix of mesangial cells in diabetic nephropathy via modulating miR-296-3p/E-cadherin signals.
Tang B; Li W; Ji TT; Li XY; Qu X; Feng L; Bai S
J Cell Mol Med; 2020 Aug; 24(15):8779-8788. PubMed ID: 32597022
[TBL] [Abstract][Full Text] [Related]
13. Involvement of miR-27a-3p in diabetic nephropathy via affecting renal fibrosis, mitochondrial dysfunction, and endoplasmic reticulum stress.
Wu L; Wang Q; Guo F; Ma X; Wang J; Zhao Y; Yan Y; Qin G
J Cell Physiol; 2021 Feb; 236(2):1454-1468. PubMed ID: 32691413
[TBL] [Abstract][Full Text] [Related]
14. Podocyte-specific overexpression of GLUT1 surprisingly reduces mesangial matrix expansion in diabetic nephropathy in mice.
Zhang H; Schin M; Saha J; Burke K; Holzman LB; Filipiak W; Saunders T; Xiang M; Heilig CW; Brosius FC
Am J Physiol Renal Physiol; 2010 Jul; 299(1):F91-8. PubMed ID: 20375116
[TBL] [Abstract][Full Text] [Related]
15. MiR-29b Alleviates High Glucose-induced Inflammation and Apoptosis in Podocytes by Down-regulating PRKAB2.
Du H; Wang Y; Zhu Y; Li X; Zhu T; Wu Q; Zha F
Endocr Metab Immune Disord Drug Targets; 2024; 24(8):981-990. PubMed ID: 38204237
[TBL] [Abstract][Full Text] [Related]
16. MiR-320a induces diabetic nephropathy via inhibiting MafB.
He M; Wang J; Yin Z; Zhao Y; Hou H; Fan J; Li H; Wen Z; Tang J; Wang Y; Wang DW; Chen C
Aging (Albany NY); 2019 May; 11(10):3055-3079. PubMed ID: 31102503
[TBL] [Abstract][Full Text] [Related]
17. Abated microRNA-195 expression protected mesangial cells from apoptosis in early diabetic renal injury in mice.
Chen YQ; Wang XX; Yao XM; Zhang DL; Yang XF; Tian SF; Wang NS
J Nephrol; 2012; 25(4):566-76. PubMed ID: 21983986
[TBL] [Abstract][Full Text] [Related]
18. Rho-Kinase Blockade Attenuates Podocyte Apoptosis by Inhibiting the Notch Signaling Pathway in Diabetic Nephropathy.
Matoba K; Kawanami D; Nagai Y; Takeda Y; Akamine T; Ishizawa S; Kanazawa Y; Yokota T; Utsunomiya K
Int J Mol Sci; 2017 Aug; 18(8):. PubMed ID: 28820432
[TBL] [Abstract][Full Text] [Related]
19. Glucose-induced reactive oxygen species cause apoptosis of podocytes and podocyte depletion at the onset of diabetic nephropathy.
Susztak K; Raff AC; Schiffer M; Böttinger EP
Diabetes; 2006 Jan; 55(1):225-33. PubMed ID: 16380497
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-770-5p is involved in the development of diabetic nephropathy through regulating podocyte apoptosis by targeting TP53 regulated inhibitor of apoptosis 1.
Zhang SZ; Qiu XJ; Dong SS; Zhou LN; Zhu Y; Wang MD; Jin LW
Eur Rev Med Pharmacol Sci; 2019 Feb; 23(3):1248-1256. PubMed ID: 30779094
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
